RxDoctor Payments Data

David Danly, MD

Psychiatry · Tyler, TXNPI 1376519272

Payments from drug & device makers

$5,477in general payments, 2019–2025

Across 317 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$861
  • Vanda Pharmaceuticals Inc.$796
  • AbbVie$749
  • Teva Pharmaceuticals USA, Inc.$713
  • Sunovion Pharmaceuticals Inc.$670
  • Otsuka America Pharmaceutical, Inc.$401
  • plus $1K from 11 others

What the payments were for

  • Food & beverage$5,31797%
  • Education$1603%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,477 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$20,586
Medicare patients
78
Services billed
230

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate52$146,567
Abilify MaintenaAripiprazole32$86,614
FanaptIloperidone27$73,488
Risperdal ConstaRisperidone Microspheres11$29,830
ClozarilClozapine25$28,155
CaplytaLumateperone Tosylate14$24,457
TrintellixVortioxetine Hydrobromide23$9,788
Aripiprazole65$7,888
Fluphenazine Hcl40$5,560
Buspirone Hcl314$4,470
Clozapine29$3,872
Lurasidone Hcl34$3,359
Chlorpromazine Hcl12$2,908
Olanzapine80$2,863
Duloxetine Hcl114$2,565

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$57$176,39763 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$401$86,61432 claims
Vanda Pharmaceuticals Inc.Fanapt$796$73,48827 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$861$24,45714 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$38$9,78823 claims
Teva Pharmaceuticals USA, Inc.Loxapine$713$81011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Tyler

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →